DUBLIN, May 29, 2024
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today
announced that Company management will participate in the following
investor conferences:
Jefferies Global Healthcare Conference on Thursday, June 6, 2024
- Fireside chat at 11:00 a.m. PT / 2:00 p.m. ET / 7:00 p.m.
IST
Goldman Sachs 45th Annual Global Healthcare
Conference on Wednesday, June 12,
2024
- Fireside chat at 7:40 a.m. PT / 10:40 a.m. ET / 3:40 p.m.
IST
Audio webcasts of the presentations will be available via the
Investors section of the Jazz Pharmaceuticals website at
https://investor.jazzpharma.com/investors/events-presentations. A
replay of the webcasts will be archived on the website for 30
days.
About Jazz Pharmaceuticals
Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma
company whose purpose is to innovate to transform the lives of
patients and their families. We are dedicated to developing
life-changing medicines for people with serious diseases — often
with limited or no therapeutic options. We have a diverse portfolio
of marketed medicines, including leading therapies for sleep
disorders and epilepsy, and a growing portfolio of cancer
treatments. Our patient-focused and science-driven approach powers
pioneering research and development advancements across our robust
pipeline of innovative therapeutics in oncology and neuroscience.
Jazz is headquartered in Dublin, Ireland with research
and development laboratories, manufacturing facilities and
employees in multiple countries committed to serving patients
worldwide. Please visit www.jazzpharmaceuticals.com for
more information.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
Kristin
Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download
multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-june-investor-conferences-302158364.html
SOURCE Jazz Pharmaceuticals plc